At a glance
- Originator Purdue Pharma
- Class Anxiolytics; Hypnosedatives
- Mechanism of Action GABA A receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Insomnia
Most Recent Events
- 23 Dec 2002 Discontinued - Preclinical for Insomnia in USA (unspecified route)
- 17 Jan 2000 New profile
- 17 Jan 2000 Preclinical development for Insomnia in USA (Unknown route)